'Mad Hatter' Event on June 10 to Benefit Moores UCSD Cancer Center

 

May 18, 2007  |  

As every Cheshire Cat knows, the Mad Hatter throws the best tea parties in Wonderland. And now he’s betting his top hat that the one he’s planning at the Moores UCSD Cancer Center will be his best ever.

The event is scheduled from 2:30 to 5 p.m. Sunday, June 10, at the Moores UCSD Cancer Center, 3855 Health Sciences Dr., La Jolla.

Susan Faerber (left) and Jennilyn Tan model sample hats.

Tickets are $25 each, which covers a healthy English high tea provided by the Center’s Healing Foods Kitchen, and a papier-mache hat – styles for men and women – ready for decorating. Guests may purchase a variety of materials – from feathers and flowers to real jewels – to create fanciful hats to keep or donate to the Cancer Center’s pediatric cancer program. Pre-decorated hats will also be available for purchase for those who would prefer this option.

Hat decorating will start at 2:30 p.m., followed by high tea, a silent auction, hat fashion show and visit from the White Rabbit.  Auction items range from gift baskets to a week-long stay in a beautiful beach house in La Paz, Mexico. Proceeds benefit the cooking class program for patients at the Center.

Reservations by June 6: 858-822-6829

#          #          #

Media Contact: Nancy Stringer, 619-543-6163,
nstringer@ucsd.edu

 

 

 




Media Contact

Share This Article


Related News

8/13/2019
UC San Diego School of Medicine has been awarded $9 million to fund research projects using human pluripotent stem cells, CRISPR and human organoids to dissect beta cell defects and create a human cel ...
8/13/2019
UC San Diego researchers discovered that removing a single enzyme in mice dramatically boosts survival from sepsis, an often fatal over-reaction of the immune system to infection. The finding provides ...
8/8/2019
The multiple sclerosis drug teriflunomide, paired with targeted cancer therapy, markedly shrinks patient-derived glioblastomas grown in mice by reaching stem cells at the tumor’s root, according to a ...
8/7/2019
In a Phase III clinical trial, the drug volanesorsen significantly reduced blood fat (triglyceride) levels in participants with a rare disease called familial chylomicronemia syndrome; finding could a ...



Follow Us